Utama › Obesiti › New York › Rochester
Kajian klinikal Obesiti di Rochester, NY
14 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Rochester (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Mengambil pesertaFasa 2
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Mengambil pesertaFasa 2
- Rochester Clinical Research, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Mengambil pesertaFasa 3
- Rochester Clinical Research, LLC, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Mengambil pesertaFasa 3
- Rochester Clinical Research, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Mengambil pesertaFasa 3
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Mengambil pesertaFasa 2
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Mengambil pesertaFasa 2
- Rochester Clinical Research, LLC, Rochester
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Mengambil pesertaFasa 3
- Rochester Clinical Research, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Mengambil pesertaFasa 3
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Mengambil pesertaFasa 3
- Rochester Clinical Research, Rochester
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- University of Rochester, Rochester
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
Mengambil pesertaKajian pemerhatian
- University of Rochester Medical Center, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Eastman Institute for Oral Health, University of Rochester, Rochester
Kajian Obesiti di bandar lain
- Houston, TX43 kajian
- Chicago, IL41 kajian
- New York City, NY40 kajian
- San Antonio, TX40 kajian
- Washington, DC33 kajian
- Orlando, FL31 kajian
- Dallas, TX30 kajian
- Boston, MA28 kajian
- Las Vegas, NV27 kajian
- Miami, FL27 kajian
- Baltimore, MD25 kajian
- Jacksonville, FL25 kajian
Kajian lain di Rochester
- Leukemia Mieloid Akut16 kajian
- Kanser Paru-paru15 kajian
- Kanser Payudara15 kajian
- Kanser (semua jenis)14 kajian
- Kanser Paru-paru Bukan Sel Kecil13 kajian
- Berat Badan Berlebihan13 kajian
- Kanser Prostat10 kajian
- Mieloma Pelbagai8 kajian
- Kanser Metastatik8 kajian
- Kanser Pankreas7 kajian
- Distrofi Miotonik7 kajian
- Kanser Pundi Kencing7 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.